CRON | Ticker Profile - Titan Protect

CRON

Cronos Group Inc.

Healthcare · Drug Manufacturers - Specialty & Generic · NGM

$2.74

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

HIGH

Data Confidence: 85.7%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$1.0B

Total market value of the company

Trailing P/E

N/A

Forward P/E

-68.00

Based on estimated future earnings — lower means cheaper

Rev Growth

+40.1%

Year-over-year revenue change

Profit Margin

-1.1%

How much profit the company keeps from each dollar of revenue

ROE

0.5%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$2.47

-10% from current price — median analyst estimate

Recommendation

STRONG_BUY

Consensus view from 1 analysts covering this stock

About Cronos Group Inc.

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.

https://thecronosgroup.com

Country: Canada Employees: 610 Industry: Drug Manufacturers - Specialty & Generic

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKUP

Price trending up with increasing momentum

Sharpe Ratio

0.335

Positive but modest risk-adjusted returns

Kelly Fraction

-0.0329

No positive edge detected — the data suggests staying out

Calmar Ratio

0.143

Drawdown risk outweighs the returns — higher risk profile

Annual Return

5.4%

Historical annualised return based on price data

Max Drawdown

-37.5%

Largest peak-to-trough decline — the worst it has been

HMM State

SIDEWAYS

Price consolidating — no clear directional bias

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

1.23

Moves slightly more than the broader market

52W High

$3.43

20% below the year high

52W Low

$1.84

49% above the year low

Avg Volume

1,476,768

Average daily shares traded — higher means easier to buy and sell

Short Ratio

1.8

Days it would take all short sellers to cover — higher means more crowded

Short % Float

2.1%

Low short interest — limited bearish positioning

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$0.00

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

0.12

Conservative use of debt — low financial risk

Current Ratio

21.87

Strong balance sheet — comfortably covers short-term obligations

Quick Ratio

20.61

Like current ratio but excludes inventory — stricter test

Gross Margin

39.6%

Revenue left after cost of goods — higher means pricing power

Operating Margin

-1.1%

Profit from core operations before interest and tax

Free Cash Flow

$-15,450,375

Negative — the business is spending more than it generates

Revenue (TTM)

$160M

Total revenue over the last 12 months

Net Income

$-1,817,000

Loss-making — spending exceeds revenue after all costs

Analyst Coverage

Analysts

Target High

$2.47

Target Median

$2.47

Target Low

$2.47

Political Trading Activity

Congressional trading disclosures involving this instrument

Date	Politician	Party	Type	Amount
21 May2026	Josh Gottheimer	Democrat	buy	1K–15K

Source: Congressional disclosure filings. View all political trades at

Insider Intelligence

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go